Gabriel Luciano
Chief Tech/Sci/R&D Officer bij CORVUS PHARMACEUTICALS, INC.
Profiel
Gabriel Luciano is currently the Vice President-Clinical Operations at Corvus Pharmaceuticals, Inc. He previously worked as the Senior Director-Clinical Operations at Pharmacyclics LLC from 2012 to 2017 and as the Senior Manager-Clinical Trail at Seagen Inc. from 2008 to 2011.
Mr. Luciano completed his undergraduate degree at the University of California, Santa Cruz.
Actieve functies van Gabriel Luciano
| Bedrijven | Functie | Begin |
|---|---|---|
| CORVUS PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01-01-2021 |
Eerdere bekende functies van Gabriel Luciano
| Bedrijven | Functie | Einde |
|---|---|---|
| PHARMACYCLICS, INC. | Corporate Officer/Principal | 01-01-2017 |
| SEAGEN INC. | Corporate Officer/Principal | 01-01-2011 |
Opleiding van Gabriel Luciano
| University of California, Santa Cruz | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| CORVUS PHARMACEUTICALS, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Pharmacyclics LLC
 Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Pharmacyclics LLC engages in developing and commercializing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. It has product candidates in clinical development and several preclinical molecules in optimization. The company was founded by Jonathan Sessler and Richard Miller in 1991 and is headquartered in Sunnyvale, CA. | Health Technology |
Seagen Inc.
 Seagen Inc. Pharmaceuticals: MajorHealth Technology Seagen Inc. is a biotechnology company, which engages in the development and commercialization of targeted therapies for the treatment of cancer. It also focuses on the advancement of therapies for solid tumors and blood-related cancers. Its products include Adcetris, Padcev, Tivdak, and Tukysa. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. | Health Technology |
